Skip to search formSkip to main contentSkip to account menu

MSN/ALK Fusion Protein

Known as: MSN-ALK Fusion Protein, Moesin/ALK Tyrosine Kinase Receptor Fusion Protein 
A fusion protein encoded by the MSN/ALK fusion gene. This protein is comprised of most of the moesin protein, including the band 4.1 region, fused to… 
National Institutes of Health

Related topics

Related topics

3 relations
Fusion GeneMSN/ALK Fusion GeneTyrosine Phosphorylation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging.
Highly Cited
2016
Highly Cited
2016
Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer's disease treatment.
Highly Cited
2015
Highly Cited
2015
Report of the AMIA EHR-2020 Task Force on the status and future direction of EHRs
Over the last 5 years, stimulated by the changing healthcare environment and the Health Information Technology for Economic and… 
Highly Cited
2014
Highly Cited
2014
VEGF121-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) signaling cascade plays a critical role in tumor angiogenesis… 
Highly Cited
2014
Highly Cited
2014
Nanoassembles constructed from mesoporous silica nanoparticles and surface-coated multilayer polyelectrolytes for controlled drug delivery
Highly Cited
2013
Highly Cited
2013
Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
Highly Cited
2013
Highly Cited
2013
pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
Highly Cited
2011
Highly Cited
2011
PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Mesoporous silica nanoparticles (MSNs) have been proposed as DNA and drug delivery carriers, as well as efficient tools for… 
Highly Cited
2008
Highly Cited
2008
Evaluation of Dimebon in cellular model of Huntington's disease
BackgroundDimebon is an antihistamine compound with a long history of clinical use in Russia. Recently, Dimebon has been proposed… 
Review
2003
Review
2003
Consensus Guidelines for Managing Postoperative Nausea and Vomiting
IMPLICATIONS We present evidence-based guidelines developed by an international panel of experts for the management of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)